DiversitySupp-ONES-Prenatal Phthalate Exposure

DiversitySupp-ONES-产前邻苯二甲酸盐暴露

• 批准号: 10851369
• 负责人: Alison Genevieve Paquette
• 金额: $ 2.94万
• 依托单位: SEATTLE CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-15 至 2024-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10851369
• 关键词: Biological Markers; Cessation of life; Chemicals; Circulation; Clinical; Computational Biology; Data; Data Set; Development; Endocrine Disruptors; Environment; Environmental Exposure; Epidemiology; Etiology; Exposure to; Functional disorder; Future; Gene Expression; Genes; Goals; Health; High Prevalence; Link; Mediating; Mediation; Messenger RNA; MicroRNAs; Molecular Profiling; Morbidity - disease rate; Multiomic Data; Newborn Infant; Outcome; Pathway Analysis; Physiological; Placenta; Policies; Pregnancy; Premature Birth; Research; Risk Assessment; Risk Factors; Role; Sampling; Therapeutic Intervention; Toxic effect; Toxicology; environmental chemical; epidemiology study; in utero; innovation; insight; mRNA sequencing; modifiable risk; multiple omics; perinatal outcomes; phthalates; potential biomarker; prenatal; prenatal exposure; transcriptomics

Project Summary Spontaneous preterm birth (sPTB) comprises the majority of preterm births (60%) and is a leading case of newborn morbidity and death and a predictor of adverse health outcomes. Despite its high prevalence, there is a limited understanding of how the in-utero environment contributes to the etiology of sPTB. Phthalates are ubiquitous endocrine disrupting chemicals that induce gene expression and physiological changes within the placenta. Epidemiological studies identify a consistent positive relationship between prenatal phthalate exposure and preterm birth. The goal of this study is to develop placental molecular signatures that can be used to mechanistically link prenatal phthalate exposure and sPTB. Placental molecular signatures can explain functional differences related to sPTB and identify targets for clinical and therapeutic interventions, including modifiable risk factors such as environmental exposures. Our research team has generated the largest placental transcriptomics dataset to date (N=760 samples) and has used this to develop transcriptomic signatures of prenatal phthalate exposure and sPTB. This study will expand our existing transcriptomic signatures to include microRNAs, which are essential to a complete molecular signature because they are highly stable, have been linked to a number of environmental exposures, and are secreted into maternal circulation where they may serve as biomarkers. Candidate microRNA studies have identified correlations between prenatal phthalate exposure and expression of placental microRNAs, but a comprehensive assessment is needed to fully understand the role of placental microRNAs in phthalate mediated toxicity. Moreover, despite the potential importance of placental microRNAs as a biomarker of sPTB, there has not been a comprehensive analysis. In this proposal, we seek to fill these research gaps and apply innovative computational biology strategies with rigorous epidemiological approaches to gain insight into the mechanistic links between prenatal phthalate exposure, placental function, and sPTB. In aim 1, we will generate microRNA data on placental samples and use this to generate a signature of prenatal phthalate exposure. We will use the matched microRNA-mRNA sequencing data to construct a global placental microRNA-mRNA network, which we will apply to identify connections between microRNAs and genes whose placneta expression is associated with different phthalate metabolites. In Aim two, we will develop a multi-omic molecular signature of sPTB using our placental microRNA-mRNA network. In aim 3, we will examine the role of the placenta as a mechanistic link between prenatal phthalate exposure and sPTB by interdisciplinary strategies including an integrated pathway analysis and a formal mediation analysis. Findings from this study will inform chemical toxicological risk assessment and policy to reduce health impacts due to phthalate exposure in pregnancy. microRNA signatures of sPTB may serve as functional biomarkers of sPTB since they can be secreted into maternal circulation and be targets for clinical and therapeutic intervention in the future.

项目摘要 自发性早产（sPTB）占早产的大多数（60%），是早产的主要病例。 新生儿发病率和死亡率以及不良健康后果的预测因素。尽管发病率很高， 对子宫内环境如何导致sPTB病因学的理解有限。二甲酸盐是 普遍存在的内分泌干扰化学品，诱导基因表达和生理变化， 胎盘流行病学研究确定了产前邻苯二甲酸酯之间一致的正相关关系 暴露和早产。这项研究的目的是开发胎盘分子标记， 用于将产前邻苯二甲酸酯暴露与sPTB机械联系起来。胎盘的分子特征可以解释 与sPTB相关的功能差异，并确定临床和治疗干预的目标，包括 可改变的风险因素，如环境暴露。我们的研究团队创造了 胎盘转录组学数据集（N=760个样本），并使用该数据集开发转录组学 产前邻苯二甲酸酯暴露和sPTB的特征。这项研究将扩大我们现有的转录组学 签名包括microRNA，这是一个完整的分子签名所必需的，因为它们是 高度稳定，与许多环境暴露有关，并分泌到母体中。 循环，它们可以作为生物标志物。候选microRNA研究已经确定了 产前邻苯二甲酸酯暴露与胎盘microRNA表达之间的关系， 需要进行评估以充分了解胎盘microRNA在邻苯二甲酸酯介导的毒性中的作用。 此外，尽管胎盘microRNA作为sPTB的生物标志物具有潜在的重要性， 进行了全面的分析。在这项提案中，我们寻求填补这些研究空白，并应用创新的 计算生物学策略与严格的流行病学方法，以深入了解 产前邻苯二甲酸酯暴露、胎盘功能和sPTB之间的联系。在目标1中，我们将产生microRNA， 胎盘样本的数据，并使用它来生成产前邻苯二甲酸酯暴露的签名。我们将使用 匹配microRNA-mRNA测序数据，构建全球胎盘microRNA-mRNA网络， 我们将应用于确定microRNA和胎盘表达相关基因之间的联系， 不同的邻苯二甲酸酯代谢物。在目标二中，我们将开发sPTB的多组学分子标记 使用我们的胎盘microRNA-mRNA网络。在目标3中，我们将研究胎盘作为一种 产前邻苯二甲酸酯暴露和sPTB之间的机制联系，通过跨学科策略，包括 综合路径分析和正式调解分析。这项研究的结果将告知化学 毒理学风险评估和政策，以减少怀孕期间邻苯二甲酸酯暴露对健康的影响。 sPTB的microRNA特征可以用作sPTB的功能性生物标志物，因为它们可以分泌到 孕妇的血液循环，并在未来的临床和治疗干预的目标。